SXT SENSIENT TECHNOLOGIES CORP
Industrial Organic Chemicals · NYSE · SEC CIK 310142 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.5%
TTM net income YoY21.7%
TTM EPS YoY21.4%
Revenue 3-yr CAGR6.3%
Net income 3-yr CAGR9.7%
Margins
Gross margin35.1%
Operating margin14.5%
Net margin9.7%
FCF margin-1.0%
EBITDA margin18.1%
Returns
ROE13.7%
ROA7.2%
ROIC (approx.)10.0%
Asset turnover0.75x
Leverage & solvency
Liabilities / assets48.0%
Debt / equity0.61x
Current ratio3.97x
Interest coverage7.95x
Cash quality & payout
Operating cash flow / net income0.71x
Accruals ratio2.1%
Payout ratio41.2%
Capex / revenue7.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.61B | $1.56B | $1.46B | $1.44B | $1.38B |
| Cost of revenue | $1.07B | $1.05B | $996.15M | $947.93M | $925.60M |
| Gross profit | $539.30M | $507.09M | $460.30M | $489.11M | $454.66M |
| R&D expense | $52.90M | $49.10M | $48.10M | $42.20M | $34.30M |
| SG&A expense | $332.17M | $315.51M | $305.27M | $292.36M | $284.63M |
| Operating income | $207.13M | $191.58M | $155.02M | $196.75M | $170.03M |
| Interest expense | $29.58M | $28.78M | $25.17M | $14.55M | $12.54M |
| Pretax income | $177.55M | $162.80M | $129.85M | $182.20M | $157.48M |
| Income tax | $43.06M | $38.13M | $36.46M | $41.32M | $38.74M |
| Net income | $134.49M | $124.67M | $93.39M | $140.89M | $118.75M |
| EBITDA | $268.23M | $251.91M | $212.84M | $249.22M | $222.08M |
| EPS (basic) | 3.18 | 2.96 | 2.22 | 3.36 | 2.82 |
| EPS (diluted) | 3.16 | 2.94 | 2.21 | 3.34 | 2.81 |
| Dividends declared per share | 1.64 | 1.64 | 1.64 | 1.64 | 1.58 |
| Weighted avg. shares (diluted) | 42.59M | 42.40M | 42.24M | 42.21M | 42.26M |
| Balance sheet | |||||
| Cash & equivalents | $36.53M | $26.63M | $28.93M | $20.92M | $25.74M |
| Receivables | $305.38M | $290.09M | $272.16M | $302.11M | $261.12M |
| Inventory | $678.22M | $600.30M | $598.40M | $564.11M | $411.63M |
| Current assets | $1.08B | $961.89M | $936.62M | $934.78M | $741.15M |
| PP&E, net | $539.30M | $491.59M | $505.28M | $483.19M | $446.48M |
| Goodwill | $439.71M | $411.77M | $424.06M | $415.71M | $420.03M |
| Intangibles | $10.12M | $11.88M | $12.11M | $18.60M | $14.97M |
| Total assets | $2.24B | $2.02B | $2.01B | $1.98B | $1.75B |
| Current liabilities | $263.58M | $270.64M | $236.31M | $272.15M | $232.31M |
| Short-term debt | $352,000 | $19.85M | $13.46M | $20.37M | $8.54M |
| Long-term debt | $709.23M | $613.52M | $645.09M | $630.33M | $503.01M |
| Total debt | $709.58M | $633.37M | $658.54M | $650.70M | $511.55M |
| Total liabilities | $1.05B | $962.81M | $961.18M | $982.02M | $807.07M |
| Shareholders' equity | $1.19B | $1.06B | $1.05B | $999.60M | $938.42M |
| Net debt | $673.05M | $606.75M | $629.61M | $629.78M | $485.81M |
| Cash flow statement | |||||
| Operating cash flow | $127.83M | $157.15M | $169.70M | $12.07M | $145.22M |
| Capital expenditure | $89.41M | $59.21M | $87.87M | $79.32M | $60.79M |
| Free cash flow | $38.42M | $97.94M | $81.83M | -$67.25M | $84.43M |
| Investing cash flow | -$92.68M | -$59.21M | -$87.62M | -$98.45M | -$35.56M |
| Financing cash flow | -$35.03M | -$81.55M | -$82.00M | $86.18M | -$107.76M |
| Depreciation & amortization | $61.10M | $60.33M | $57.82M | $52.47M | $52.05M |
| Stock-based compensation | $13.95M | $10.08M | $8.93M | $16.14M | $9.57M |
| Dividends paid | $69.61M | $69.40M | $69.22M | $68.92M | $66.69M |
| Share buybacks | — | — | $0 | $0 | $42.51M |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.